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“What comes from the heart, goes to the heart” 
“Det som kommer från hjärtat, går till hjärtat” 
Samuel Taylor Coleridge 
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ABSTRACT 
Background: Chronic heart failure (CHF) is a serious illness, with a profound 
impact on the patient. Poor health-related quality of life (HRQoL) as well as anxiety 
and depression are prevalent in CHF and predict mortality and rehospitalization, yet, 
psychosocial factors are infrequently treated and cared for. 
Aim: To gather scientific evidence on illness perception and coping strategies to 
predict emotional well-being in patients with CHF and to establish a measurement 
model of coping strategies. Furthermore, to evaluate a nurse-led psychoeducational 
intervention, Coping Effectiveness Training (CET) adapted for patients with CHF. 
Methods: Studies I-III were cross sectional. Study IV was a randomized controlled 
trial aimed to improve emotional well-being (one-year follow-up). All studies used 
patient reported outcome measures and clinical data via medical journals. 
Results: Younger age and male gender were associated with higher levels of alcohol 
usage and/or drugs to cope, p < 0.01. Poor sense of coherence was associated with 
maladaptive coping (I). A four factorial model of Brief COPE displayed the best 
psychometric properties (II). Avoidant coping influenced negative affect (NA) (I), 
worse HRQoL (II) and greater anxiety and depression (III). CET (IV) improved 
personal control in the intervention group (IG) compared to the control group (CG), 
p = 0.036. Improved scores for the IG were detected in emotional well-being and 
HRQoL, p = ns. The IG demonstrated reduced NA, p = 0.022, excluding cases with 
clinical anxiety and depression. Time to cardiovascular readmission or death was 
non-significantly lower in the IG vs the CG (Hazard ratio 0.58 [0.29-1.18]) adjusted 
p = 0.135. 
Conclusions: Personal resources seemed to influence the coping strategies used by 
patients with CHF. Avoidant coping had an adverse influence on emotional well-
being and illness perception in CHF. The perceived sense of control and illness 
burden were of importance for emotional well-being. A CET intervention for 
patients with CHF increased sense of control over the illness. CET also reduced NA 
in patients with no or mild symptoms of anxiety and depression. 
Keywords: Heart failure; Coping; Illness perception; Emotional well-being; Quality 
of life; Intervention; Randomized controlled trial 
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1 INTRODUCTION 
Chronic heart failure (CHF) is a serious and incurable illness, shortening the life 
expectancy of about 26 million people worldwide who are currently living with 
CHF 1. The poor prognosis of CHF and rehospitalization rates are comparable to 
those in the common forms of cancer 2, 3. CHF has been reported to be the leading 
cause of hospitalizations in patients aged over 65 years 4, 5 and the fourth most 
common reason for all hospital care 4, 6. The economic cost of heart failure care is 
very high and accounts for one to three percent of the total healthcare expenditure in 
several countries 1. The total annual cost of heart failure care per patient in Sweden, 
including primary health care, has been reported to be € 36500 7. 
Individuals living with CHF are affected by the illness in many dimensions of their 
lives 8. Patients with CHF experience physical limitations 9, poor health-related 
quality of life (HRQoL) 10, emotional distress 11, social isolation and existential 
concerns 12. Caregivers, such as family members, can also experience distress and 
social isolation 13. All of these aspects, and the resulting life style adjustments, 
challenge the resources of patients with CHF to cope with their life situation 14.  
Over the years, I have cared for many patients with CHF in hospital wards and at a 
nurse-led heart failure outpatient clinic. It was through my clinical experience that I 
was inspired to examine coping and emotional well-being in patients with CHF. I 
observed that these patients coped with their illness in different ways and I wanted 
to find out what factors could be related to the patients’ coping abilities. I decided to 
investigate this further through research. Later on, the opportunity arose to develop, 
implement and evaluate an education program for patients with CHF, aimed at 
enhancing their adaptive coping skills and perception of the illness, in order to 
improve their life situation. This thesis could contribute to raised awareness and 
increased knowledge about coping and emotional well-being in patients with CHF 
and to point towards what kind of support these patients need in order to improve 
their life situation.   
 2 
2 BACKGROUND 
2.1 CHRONIC HEART FAILURE 
2.1.1 Definition, epidemiology and aetiology 
Chronic heart failure (CHF) is defined as a syndrome in which the patient has 
typical symptoms and signs resulting from an abnormality of cardiac structure or 
function. Typical symptoms of CHF are: shortness of breath, peripheral oedema and 
fatigue, and typical signs are: elevated jugular venous pressure, pulmonary crackles, 
and displaced apex beat 15. The main measurement of the cardiac function is left 
ventricular ejection fraction (LVEF), i.e. the percentage of blood volume pumped 
out in systole from the left ventricle, which should normally be > 50 percent. A 
considerable proportion of patients (40-50%) have CHF with normal LVEF 15. The 
severity of symptoms and physical ability is classified in to four functional classes, 
New York Heart Association Classification (NYHA class) I-IV 15 as displayed in 
Table 1.  
Table 1. New York Heart Association Classification (NYHA class) according to European 
Society of Cardiology guidelines 15. 
NYHA class I No limitation of physical activity. Ordinary physical activity 
does not cause undue breathlessness, fatigue, or palpitations. 
NYHA class II Slight limitation of physical activity. Comfortable at rest, 
but ordinary physical activity results in undue 
breathlessness, fatigue, or palpitations. 
NYHA class III Marked limitation of physical activity. Comfortable at rest, 
but less than ordinary physical activity results in undue 
breathlessness, fatigue, or palpitations. 
NYHA class IV Unable to carry on any physical activity without discomfort. 
Symptoms at rest can be present. If any physical activity is 
undertaken, discomfort is increased. 
 
In developed countries approximately two percent of the population is diagnosed 
with CHF and the prevalence rises sharply with age where ≥ 10 percent of people 
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over 70 years have CHF 15. An epidemiological study in Sweden confirmed two 
percent prevalence and showed that the mean age for an individual diagnosed with 
CHF was 77 years, where the mean age for women was 80 years and for men 74 
years. The incidence was about 3.8/1000 persons per year 16.  
CHF has many primary causes, where the major causes are hypertension and 
ischaemic heart disease. Other causes could be cardiomyopathy, alcohol abuse and 
valvular heart disease 15. Co-morbidities frequently occur in patients with CHF and 
contribute to increased morbidity, mortality and impaired quality of life (QoL). 
Common co-morbidities are: chronic kidney disease, diabetes, anemia and 
depression 17, 18.  
CHF is divided into heart failure with reduced LVEF (HF-REF) and heart failure 
with preserved ejection fraction (HF-PEF) 15. Patients with HF-PEF display 
somewhat different clinical characteristics than patients with HF-REF; they are 
older, more often female and more likely to have hypertension 19. HF-PEF is 
defined by LVEF > 45-50 %, measures of diastolic dysfunction or other objective 
measures of LV dysfunction, including increased levels of natriuretic peptides 15. 
2.1.2 Prognosis 
The five-year survival rate from the first recorded diagnosis of CHF has been found 
to be 48 percent in the Stockholm region, with two million inhabitants, and was 
lower than for the age-matched entire Swedish population 16. Another study from 
Ireland reported a better five-year survival rate of 64 percent, however, it was lower 
compared to a non-CHF cohort displaying a survival rate of 80 percent 20. Patients 
with HF-PEF have a better survival rate than patients with HF-REF 20, 21. A 
decrease in incidence and mortality of CHF has been found over time, which could 
be attributed to improved treatment and control of risk factors, although the 
prevalence has remained at the same level 16. There are many predictors of mortality 
and hospitalizations in CHF, for example: older age, diabetes, lower LVEF, higher 
NYHA class and reduced QoL 22, 23.  
Research has shown the trajectory of risk of readmission to hospital and death after 
being hospitalized for CHF in patients over 65 years. The highest risk of 
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readmission was within the first two months after being hospitalized, whereas risk 
of death declined rapidly. In total, the one-year readmission rate was 68 percent and 
the mortality rate 36 percent 24. A large global study reported a 30-day hospital 
readmission rate of 16 percent after being hospitalized for CHF 25. 
The survival rate in CHF is comparable to many cancer diagnoses 3, 26, yet the 
trajectory for the end of life for individuals with CHF differs. The typical trajectory 
is characterized by a gradual decline in function, with intermittent acute worsening 
of the CHF, followed by a return to near their habitual condition prior to the 
exacerbation. Eventually, one of these exacerbations will be followed by death. 
However, death may also come suddenly and unexpectedly 27. 
2.1.3 Symptom burden 
CHF exerts an impact on several aspects of the individual’s life, such as their 
physical, emotional, social, intellectual and existential dimensions 8. The symptom 
prevalence and symptom burden is high amongst patients with CHF 28, 29. The 
prevalence of symptoms has been reported to be as high as a mean of 15 28 and even 
up to 19 symptoms 29, where shortness of breath and lack of energy were the most 
prevalent symptoms. The majority of the patients also experienced pain 28, 29. 
Symptoms perceived as the most burdensome were: shortness of breath, difficulty 
sleeping, lack of energy and numbness/tingling in hands or feet 28, 29. Another 
symptom described as causing suffering is thirst, which is caused by the condition 
itself as well as the treatment 30. Emotional distress, such as worrying and feeling 
sad, has also been reported with high prevalence 28, 29. Worries could, for example, 
concern the end of life 12. Impairment of the patients’ cognitive abilities is also quite 
common 31.  
The physical limitations caused by CHF alerts the individual to find strategies to 
solve practical tasks in daily life, but there could also be a lack of self-confidence in 
performing physical activities. The limitation in physical capacity also affects the 
patient's social role, where their role in society and family is diminished as well as a 
loss of their social network 9. A literature review found that men were most 
bothered with physical limitations causing restrictions to daily activities, whereas 
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women were most concerned with restrictions interfering with their ability to give 
support to family and friends 32. A qualitative study has described the process of 
becoming a patient with CHF as gradually taking on a new identity and finding 
meaning with their new life situation. Different phases of this process were 
identified, starting with a crisis event and ending up in accepting the new life 
situation, putting it into a context and making lifestyle adjustments 33. 
2.1.4 Treatment and care 
There is no cure for CHF, although treatment has certainly made a considerable 
change for the better for patients with heart failure 34. Guidelines from the European 
Society of Cardiology (ESC) state that the treatment of CHF aims to alleviate 
symptoms and signs of CHF, prevent hospital admission, and improve survival. The 
non-pharmacological non-device/surgical interventions that have received 
recommendations with an evidence level are exercise training and implementation 
of care in a multidisciplinary framework 15. 
2.1.4.1 Pharmacological treatment 
The pharmacological treatment recommended for all patients with CHF is 
angiotensin-converting enzyme (ACE) inhibitors and beta-blockers. An alternative, 
if the ACE inhibitor is not tolerated, is angiotensin receptor blockers (ARB). The 
pharmacological base treatment of CHF has proved to improve survival and QoL 
and reduce hospitalizations 15. If necessary, the patients also have diuretics to 
alleviate symptoms. If the patient remains in NYHA II-IV after having been given 
the base treatment, mineralcorticoid/aldosterone receptor antagonists (MRA) should 
be administered. The next step in treatment for patients with NYHA II-III, if they 
have a sinus rhythm with a heart rate ≥ 70 beats per minute in combination with 
LVEF ≤ 35 percent, is to give Ivabradine. For patients in NYHA class III-IV, 
digoxin and hydralazine and isosorbide dinitrate (H-ISDN) could be considered 15. 
2.1.4.2 Device treatment 
Cardiac resynchronization therapy (CRT) is recommended for patients in NYHA II-
IV who exhibit an LVEF ≤ 35 percent, QRS duration ≥ 120 milliseconds and a left 
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bundle branch block 15. The CRT could also be combined with an implantable 
cardioverter defibrillator (ICD). The rationale for treatment with ICD is the 
prevention of sudden cardiac death and can be given both as primary and secondary 
prevention 15. Positive outcomes from CRT and ICD in CHF have been found, with 
improved QoL and reduced hospitalizations and mortality 35. 
2.1.4.3 Surgery 
Coronary revascularization is recommended for patients with CHF who also have 
angina and coronary artery disease. Valve surgery is an option for patients with 
valvular heart disease. For patients with end-stage CHF, heart transplantation, could 
be an option, however, this treatment is for a selected group of patients and the 
organ donations are limited. An alternative could be mechanical circulatory support, 
such as left ventricular assist device 15. 
2.1.4.4 Exercise training 
Exercise training for patients with CHF has been shown to improve exercise 
tolerance, HRQoL and heart failure hospitalization rates and has, via ESC 
guidelines, received a recommendation class of I with an evidence level of A 15, 36. 
Despite this high recommendation level exercise training is poorly implemented in 
the clinical care of patients with CHF. Exercise training can consist of: endurance 
aerobic training, strength/resistance training and respiratory training 37. 
2.1.4.5 Multidisciplinary management of heart failure care 
Several studies have shown benefits of multi-professional, organized and managed 
care of patients with CHF 38 39, 40. However, there is no consensus on what the 
optimal structure for organized management of heart failure care is and it might also 
differ between countries and regions 41. 
The goal of the management of heart failure care is to provide a chain of care that 
functions across primary and hospital care, so that the patient with CHF receives 
optimal care, in order to improve survival and QoL. Essential resources within the 
heart failure management care are: heart failure specialist cardiologists and nurses, 
heart failure outpatient clinics and an adherence to common guidelines 41. The 
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multi-professional team could also include: physiotherapists, dieticians, primary 
care providers, social workers, psychologists and pharmacists 42. Important 
components in heart failure care are: structured follow-ups with patient education, 
optimization of medical treatment and psychosocial support as well as improved 
access to health-care, including palliative care 41. 
2.1.4.6 Nurse-led heart failure clinic 
Specialist heart failure nurses play an important role in the multidisciplinary care of 
patients with CHF. An important component of the organized care for patients with 
CHF is nurse-led heart failure clinics 41. The nurse-led heart failure clinics have 
shown positive outcomes for patients with CHF with regard to better organized care 
43, improved survival, self-care behaviour 44, reduced hospital readmissions 45 and 
functional status, as well as optimal target doses of heart failure medication 46. A 
Cochrane review found that case management, i.e. intense monitoring of patients 
following discharge, with telephone calls and/or home visits by specialist heart 
failure nurses, to be especially beneficial 40. The specialist heart failure nurse 
conducts independent patient consultations where symptoms and signs of CHF are 
examined through, for example, auscultations of lungs and inspections of oedema. 
The nurse provides the patient and family members with education on heart failure 
and self-care according to the guidelines, as well as psychosocial support. 
Prescribed pharmacological heart failure drugs are up-titrated according to protocol 
and diuretic doses are adjusted as required. The patients receive a tailored treatment 
according to what they need and can tolerate. Cardiologists serve as consultants to 
the nurses 44, 45.  
2.1.4.7 Palliative care 
The aim of palliative care for patients with CHF is to prevent and alleviate suffering 
and to improve QoL for the patients and their families 47. Although the poor 
prognosis and symptom burden is equivalent to cancer 2, 3, patients with CHF are 
less likely to be supported by hospice and opiates and more likely to die in hospital 
than patients with cancer 48. The palliative care in patients with CHF is currently 
considered to be insufficient and is suggested to be an integral part of heart failure 
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care 49. Components of the palliative care are, for instance, to establish an advanced 
care plan with documentation of the patients’ preferences for treatment and 
resuscitation, identifying end-stage heart failure, and optimizing symptom 
management at the end of life 47. 
2.1.4.8 Telemonitoring 
Telemonitoring, remote monitoring and support, of patients with CHF is becoming 
an increasing part of heart failure care 50. Telemonitoring could, for instance, 
involve self-care guidance via a tablet device and weight monitoring 51 as well as 
wireless implantable haemodynamic monitoring 52. A meta-analysis of randomized 
controlled studies with telemonitoring in a Cochrane study found reduced all-cause 
mortality and, in combination with structured telephone support, a reduction in CHF 
hospitalizations. In addition, several of the included studies improved QoL and 
reduced healthcare costs 53. However, such studies have shown inconclusive results 
and more research is required 54. 
2.1.5 Self-care management 
Self-care is defined as the activities an individual carries out in order to maintain 
life, health and well-being 55. Orem’s theory of self-care has been developed further 
in to a situation-specific theory of heart failure self-care 56. The situation-specific 
theory focuses on three self-care processes: maintenance which typically involves 
treatment adherence, symptom perception and management which are the responses 
to symptoms when they occur 56. ESC guidelines have outlined a description of 
topics that should be covered in the education of patients with CHF and family 
members. In relation to these topics knowledge about lifestyle changes alone is not 
the only goal, but also self-care behaviour and skills 15. Research has shown that 
knowledge about heart failure and self-care management is not sufficient in order 
for the individual to carry out recommendations for making lifestyle adjustments 57. 
For example, the patients’ emotional state can influence their self-care behaviour 58, 
hence there are recommendations to screen for barriers to self-care 50. 
Symptom recognition and symptom monitoring is an integral part of self-care. 
Symptoms of worsening heart failure could be increasing dyspnea and oedema or a 
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sudden unexpected weight gain of > 2 kg in three days. If this happens the patient 
can increase the diuretic dose temporarily and/or contact the health-care. Regular 
weighing, in order to recognize a potential sudden weight gain, is recommended. A 
flexible diuretic regime could be recommended, if needed, and requires detailed 
instructions from the informer 15. Adherence to the treatment plan is also essential 
for self-care 15.  
There has been a tradition of advising fluid and sodium restriction to patients with 
CHF, however, the evidence to support these restrictions are scarce and 
inconclusive 50. A study comparing restricted and flexible fluid intake based on 
weight found no differences, while another study has shown benefits from fluid as 
well as sodium restriction 59, 60. The current recommendation for fluid intake is a 
restriction of between 1.5 - 2 liter/day in patients with severe CHF 15. A routine 
fluid restriction is not recommended 50. Excessive salt intake should be avoided, 
especially for patients who are symptomatic 50.  
Weight loss should be given attention as it can be a sign of cachexia. Anorexia is a 
common problem and contact with a dietician might be necessary. It may be 
advisable to divide daily meals into more frequent but smaller meals. Obesity 
should also be managed 15, 50. 
Restricted alcohol intake is recommended up to a maximum of two units per day in 
men or one unit per day in women. A unit is equivalent to one glass of wine for 
example. However, alcohol abstinence should be advised for patients with alcohol 
induced cardiomyopathy 15. Research has shown that moderate wine consumption 
was associated with better health outcomes for patients with CHF 61. Ceasing 
smoking is strongly recommended and the intake of illicit drugs is discouraged 15. 
In order to reduce the risk of sleeping disorders obese patients are recommended to 
lose weight, cease smoking and abstain from alcohol use. For health-care 
professionals it is important to detect and provide appropriate treatment for sleep-
disordered breathing 15, 50. 
Daily moderate physical activity is recommended for all patients with CHF; and for 
patients with stable CHF exercise training is advised 50. A concern for many 
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patients and their partners is sexual activity 62 and research has shown they want 
information regarding such matters 63. Individualized counselling is recommended 
for the patient and their partner to be reassured about engaging in sex and for 
discussing problems 15, 50. 
Travel is possible for patients with CHF but may require preparation such as 
carrying extra medication, medical history records as well as a medication list. 
When flying, flight socks are advised and fluid intake might need adaption when 
travelling to hot countries 15, 50. Patients with CHF are recommended to take 
immunization against influenza and pneumococcal disease 15. 
Regarding psychosocial aspects it is recommended that patients should be informed 
that depressive symptoms as well as cognitive dysfunction are commonly 
associated with CHF. The significance of social support should also be explained 15. 
A patient’s confidence in undertaking self-care management of CHF, i.e. self-
efficacy, is influenced by psychosocial factors 64. There is limited evidence of the 
efficacy of psychological as well as pharmacological interventions for emotional 
distress in the context of CHF 50. The ESC guidelines are lacking information on 
how psychosocial support and psychosocial self-care skills could be provided in a 
systematic manner. 
2.2 CONCEPTUAL FRAMEWORK 
This section explains the concepts, models and theories that support the conceptual 
framework in this thesis and reviews the empirical research on how the concepts are 
manifested in CHF. Figure 1 presents the components of the conceptual framework. 
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Figure 1. Graphic overview of the components of the conceptual framework of this thesis 
showing a person with CHF to whom all the components relate to. 
 
 
2.2.1 Emotional well-being 
2.2.1.1 Definition 
The concept of well-being is complex and multidimensional. In the literature, well-
being has been described rather than defined 65. A recent attempt to define well-
being defines the concept as a balance point between resources and challenges. 
Well-being is experienced when the individual’s psychological, social and physical 
resources can meet the demands of a psychological, social and/or physical 
challenge 65. The World Health Organization (WHO) refers to well-being in the 
context of defining health, as “a state of complete physical, mental and social well-
being and not merely the absence of disease or infirmity” 66. WHO’s definition of 
health has been critiqued for defining happiness rather than health 67. The 
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importance of measuring well-being has become increasingly recognized and well-
being has been measured in many European countries at a national level 68. 
Moreover, well-being is regarded by the general public to be an important concept 
to measure 69. 
Emotional well-being, as part of the general concept of well-being, has no clear 
definition but could be defined as the experience of feeling a pleasant rather than 
unpleasant affect in one’s life 70. Emotions fluctuate but are suggested to move 
around a mean level of mood, which differs between individuals. This mean level of 
pleasant or unpleasant mood, that is stable over time and situations, constitutes the 
core of an individual’s emotional well-being 70. Furthermore, the frequency of the 
experience of pleasant affect has more importance than the intensity of the emotions 
for emotional well-being. This is because intense emotions are rare and people who 
experience pleasant emotions intensely are also more likely to experience 
unpleasant emotions intensely 70. The two-dimensional structure of affect, positive 
affect (PA) and negative affect (NA) represents the major dimensions of emotional 
experience 71. Positive emotions are suggested to contribute to improved emotional 
well-being 72. High PA is characterized by feeling enthusiastic, engaged and pleased 
whereas low PA is a state of feeling sad and lethargic. High NA, on the other hand, 
regards feelings of distress, anger, fear, guilt and nervousness, and low NA is a state 
of being relaxed and calm 71, 73. Both NA and PA can co-occur during chronic stress 
where PA is of importance for adaptive functions 74.  
Emotional well-being has also been measured in research with symptoms of 
depression and anxiety, where lower symptoms were an indicator of better 
emotional well-being 75-77. In addition, an emotional well-being subscale in a self-
reporting questionnaire has shown significant negative correlations with measures 
of anxiety and depression 78. In contrast, anxiety and depression are often referred to 
as emotional distress. Emotional distress has been defined in, for example, cancer 
literature as an unpleasant emotional experience, such as anxiety and depression, 
which might interfere with the ability to cope with the illness 79, 80. Emotional well-
being and emotional distress have been suggested to be inversely related and 
interact in a dynamic process 81. 
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2.2.1.2 Emotional well-being in patients with CHF 
Patients with CHF suffer from impaired emotional well-being. The prevalence of 
emotional distress is higher among patients with CHF compared to healthy elders 
and to other cardiac patient groups 11. Reported prevalence of depression ranges 
from 13 to 77 percent 82. A recent meta-analysis of the prevalence of anxiety in 
patients with CHF reported a pooled prevalence of 32 percent, ranging from 6 to 72 
percent 83. Several studies have identified depression as an independent predictor of 
mortality and readmission to hospital in patients with CHF 18, 84-89. Depression has 
also been associated with worse HRQoL 90-92. Anxiety has been linked to higher 
readmission rates and lower HRQoL 93, 94. Furthermore, anxiety and depression 
predict a decline in physical functioning in patients with CHF 95. In contrast to these 
findings, PA has been found to be protective against a 10-year incidence of 
coronary heart disease 96. PA has also been associated with reduced inflammatory 
biomarkers 97 and better self-care management in patients with CHF as well as with 
perceived positive changes in health behaviour 58. Low levels of PA have been 
shown to predict impaired health status in patients with CHF 98. Despite the 
detrimental outcomes of impaired emotional well-being in patients with CHF, 
psychosocial factors are infrequently assessed and treated in clinical practice 99, 100. 
2.2.2 Health-related quality of life (HRQoL) 
2.2.2.1 Definition 
HRQoL specifies the general concept of QoL from a health perspective, including 
aspects of physical, psychological and social functioning and is a relating concept to 
well-being 101. HRQoL is defined by how health influences the individual’s ability 
to function and the perceived well-being in the physical, psychological and social 
domains of life 102.  
2.2.2.2 HRQoL in patients with CHF 
Individuals with CHF experience poor HRQoL 10, 103. In addition, HRQoL in 
patients with CHF is worse compared to age-matched healthy people 104-106. Poor 
HRQoL has been found to predict mortality and rehospitalization in patients with 
CHF 23. Several studies have found impaired physical functioning, as measured by 
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NYHA class, to be associated with worse HRQoL 28, 107, 108. Younger age has also 
been linked to worse HRQoL 28, 108, 109 and one study found that older patients had 
better HRQoL than younger patients despite higher NYHA class. However, older 
patients were at higher risk of worsening HRQoL as a result of deterioration in 
physical functioning 110. Patients younger than 65 years were concerned about loss 
of role and activities and it has been suggested that older people might have altered 
their expectations 109. Women have reported worse physical functioning in HRQoL 
than men 107, 111. Psychosocial factors, such as greater social support, have been 
shown to be associated with better HRQoL when controlled for age, gender and 
NYHA class 112. Furthermore, when controlled for disease severity, depression has 
been found to influence HRQoL 113. One study demonstrated that many patients 
experience an improvement in HRQoL one month after being hospitalized for heart 
failure and those patients who didn’t experience an improvement were at higher risk 
of rehospitalization and mortality even when risk factors were controlled for 114.   
2.2.3 Coping 
2.2.3.1 Theory of stress and coping 
Lazarus and Folkman’s cognitive transactional theory of stress and coping provides 
a framework for the process of coping with stressful situations. Coping is defined as 
“constantly changing cognitive and behavioural efforts to manage specific external 
and/or internal demands that are appraised as taxing or exceeding the resources of 
the person” 115. According to Lazarus and Folkman there are two main functions of 
coping: managing or altering the problem causing the distress (problem focused 
coping) or regulating the emotional response to the stressful situation (emotion 
focused coping) 115. How the individual cognitively appraises the situation is also 
important in the coping process. In a primary appraisal the situation is assessed as 
being stressful or not and in a secondary appraisal there is a judgment of what might 
and can be done. In a reappraisal the outcomes of the coping strategy are evaluated, 
based on new information after a coping effort, and may result in a changed 
appraisal. The cognitive appraisal processes are usually implicit. That is, the 
appraisals are automatic rather than based on rational reasoning 115. The coping 
strategies can be regarded as either adaptive or maladaptive, depending on whether 
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the coping strategy chosen is suitable for the situation. Adaptive coping occurs 
when the coping strategy fits the changeability or controllability of the situation. If 
the situation is changeable or controllable problem focused coping is most 
appropriate, while if the situation is unchangeable or uncontrollable emotion 
focused coping is most suitable. In contrast, maladaptive coping occurs when 
emotion focused coping is employed in a changeable situation and problem focused 
coping in an unchangeable situation 116, 117. Maladaptive coping results in emotional 
distress 118. A thematic overview of the theory is displayed in Figure 2. 
Derivatives of Lazarus and Folkman’s theory of stress and coping occur. Carver, 
Scheier and Weintraub have, in their development of a self-assessment 
questionnaire for coping strategies, separated coping strategies generally viewed as 
maladaptive, such as denial and behavioural disengagement, from emotion focused 
coping 119, which Lazarus and Folkman conceptually included in emotion focused 
coping 115. 
Figure 2. Thematic overview of Lazarus and Folkman’s theory on stress and coping. 
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2.2.3.2 Dispositional coping 
Lazarus and Folkman’s theory of stress and coping focus on situational coping 
where coping strategies change through different stages of the stressful transaction 
120. The other way of modelling coping strategies is through the concept of 
dispositional coping which, in contrast to situational coping, is a rather stable 
pattern of coping strategies across different situations. That means that the 
individual has acquired a habitual way of coping with stress, which in turn can 
affect how the individual reacts to new situations 121. In line with the dispositional 
way of modelling coping strategies, dispositional modelling of appraisal has also 
been suggested. That is, the individual is predisposed to consistently appraising a 
stressor as, for example, challenging or threatening. An individual could thereby be 
either more resistant or vulnerable in stressful situations 122. 
2.2.3.3 Coping with chronic illness 
Moos and Holahan proposed a framework for coping with chronic illness which is, 
in part, based on crisis theory 123. In crisis theory the focus is on how the individual 
manages major life crises. Chronic illness, such as CHF, causes an unbalance and 
the individual tries to establish equilibrium. The new balance can be achieved either 
through adaptive coping or maladaptive coping, which will have different 
consequences for health. The coping process is also believed to be influenced by: 
personal resources, cognitive appraisal, social and physical context and health-
related factors such as illness severity and symptoms 123. 
2.2.3.4 Coping in patients with CHF 
An individual living with CHF needs to cope with the symptom burden of the 
illness in all dimensions of his or her life and make life style adjustments 8, 33. The 
patients also need to cope with the uncertain nature of CHF 124. The importance of 
coping for health outcomes in patients with CHF has received increasing attention 
in research 125. Studies have shown that individuals with CHF who employ problem 
solving coping strategies, such as planning and taking an active approach to solve a 
problem, have fewer depressive symptoms 126, better subjective well-being 127, less 
fatigue and more vigour 128. Active coping in combination with acceptance has been 
  17 
found to predict fewer physical symptoms 129. In contrast to these findings another 
study found approach coping, which included active coping, positive reframing, 
planning, acceptance, seeking emotional support and seeking instrumental support, 
not to be associated with physical functioning in patients with CHF 130. Emotion 
focused coping, such as acceptance, positive reframing and religious coping have, 
in a study in the USA, been linked with an increased sense of meaning of life 131.  
Avoidant coping, such as denial and behavioural disengagement, has on the other 
hand, been associated with increased depression, anxiety and fatigue, worse 
HRQoL and physical functioning as well as increased mortality 14, 126, 128, 130, 132, 133. 
In addition, a literature review has suggested avoidant coping to be negatively 
associated with adaptive self-care in patients with CHF 134. 
Patients with CHF also use social support to help them adapt to their new life 
situation, but social support could also be unhelpful in situations where there is 
excessive help, too much information or criticism 135. 
Few studies have examined the influence of age, gender and NYHA class on coping 
strategies in patients with CHF. One study, using narratives from semi-structured 
interviews, found avoidance coping and acceptance to be more salient in patients 
aged over 70 years. Avoidance was also more salient in patients with moderate to 
severe limitation in physical functioning 136. In contrast, another study found that 
patients with CHF who experienced more physical symptoms tended to use more 
symptom focused coping, such as resting or taking medication 129. Gender 
differences in coping strategies in patients with CHF have been elucidated in a 
study where men used more emotion focused and avoidant coping strategies, 
whereas women used optimistic coping strategies and were more hopeful about the 
future 137. 
2.2.3.5 Measuring coping strategies in patients with CHF 
There is a wide range of self-assessment questionnaires used in research to measure 
coping strategies in patients with CHF 14, 126, 128, 130, 132, 138, 139. Among these self-
assessments questionnaires are: Dealing with illness-R checklist 140, Coping 
Inventory for Stressful Situations (CISS) 141, Ways of Coping Questionnaire (WCQ) 
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142, Side Effect Coping Questionnaire (SECope) 143, Coping Orientation to 
Problems Experienced (COPE) 119 and Brief COPE 144. However, most of the 
studies have used COPE or Brief COPE when measuring coping strategies in 
patients with CHF 125. The 28-item Brief COPE is a shorter version of the 60-item 
COPE, which reduces the respondent burden 119, 144. However, there are still many 
subscales in Brief COPE (14 subscales) which could cause some practical as well as 
conceptual problems when measuring coping strategies such as: several analyses, 
fragmentation of results and overlapping coping strategies. In order to solve these 
problems the subscales of Brief COPE have been modelled into higher order 
structures, consisting of fewer factors of coping in the context of CHF 127, 130, 145, 146. 
However, there is no consensus about the theoretical or empirical foundations of 
how to group the subscales of Brief COPE in to a higher structure.  
2.2.4 Illness perception 
2.2.4.1 Common sense model of self-regulation 
When a person is faced with an illness or health threat he or she begins to have 
thoughts, ideas and emotions in the form of so called representations about their 
illness in order to make sense of the illness. These illness perceptions can vary from 
person to person 147. An influential theoretical framework for illness perception is 
the Common Sense Model (CSM) of self-regulation 148. The CSM proposes that 
stimuli, such as symptoms from the illness, give rise to both cognitive and 
emotional representations in parallel. Coping strategies are then applied to cope 
with the different representations that have arisen. The efficacy of these strategies 
are then appraised by the individual and incorporated into their representations. For 
example, a symptom can give rise to representation of danger (cognitive) and fear 
(emotional). The individual takes action in order to control the danger, e.g. by 
giving up smoking 149.  
In the CSM model the cognitive representation consists of five components: 
identity, timeline, consequences, cause and control. Identity deals with the 
symptoms the person ascribes the illness. Timeline is the perceived duration of the 
illness. Consequences are the beliefs about the impact of the illness in one’s life. 
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Cause represents the personal ideas about the causes of the illness. Control is the 
belief of how manageable the illness is by personal effort or treatment 149. 
2.2.4.2 Illness perception in patients with CHF 
Several studies have examined illness perception in patients with CHF 150-158. Illness 
perception has been shown to be of importance for emotional well-being 153, 156, 
HRQoL157, self-care behaviour 152, 155 as well as readmission to hospital 158. 
However, only one of these studies examined the association of illness perception 
with coping strategies and emotional distress, where beliefs about greater 
consequences of the illness and less personal control were associated with 
maladaptive coping strategies and greater emotional distress 153.  
2.2.5 Sense of coherence 
2.2.5.1 Definition and salutogenic theory 
Antonovsky defined the concept of sense of coherence (SOC) as “a global 
orientation that expresses the extent to which one has a pervasive, enduring though 
dynamic feeling of confidence that one's internal and external environments are 
predictable and that there is a high probability that things will work out as well as 
can reasonably be expected” 159. SOC is suggested to consist of three parts; 
meaningfulness, comprehensibility, and manageability 160. In the salutogenic theory, 
where the concept of SOC originates from, the focus is on resources that promote 
health rather than risk factors for illness (pathogenic) 161. Theoretically, SOC is 
regarded as an internal resource to cope with stressful situations in life 162. The 
salutogenic theory suggests that an individual is never entirely ill or entirely 
healthy, but is moving in a continuum between the two poles of illness and health 
159.  
2.2.5.2 Sense of coherence in patients with CHF 
Studies regarding the level of SOC in patients with CHF have shown inconclusive 
results. Two studies found high levels of SOC in patients with CHF 163 even though 
they had low HRQoL 104, in contrast to another finding demonstrating low levels of 
SOC in patients aged over 85 years 164. High levels of SOC have been indicated to 
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be associated with better self-management of CHF 165, more coping resources 163, 
and more satisfying social relationships 166 whereas low levels of SOC have been 
linked to greater mental fatigue such as less ability to concentrate 167.  
2.3 INTERVENTIONS TO IMPROVE EMOTIONAL WELL-BEING 
There are many randomized controlled trials (RCT) that have examined 
interventions with self-care management in patients with CHF 168, however, the 
focus of the education has been mainly on physical aspects of self-care and 
symptom monitoring rather than focusing on behaviour, skills and psychosocial 
factors. The RCTs that have been conducted with psychoeducational interventions 
in patients with CHF are few and some of the studies are pilot studies with a small 
sample size (n=20 and n=43), yet there were still some positive results found such 
as improved mood state and increased sense of control 169, 170. Relaxation training 
for patients with CHF has shown improvements in the psychological, social and 
spiritual aspects of HRQoL 171, 172. In a prospective cohort study, with a 
geographical control group, the intervention consisted of mindfulness training and 
training in coping skills, resulting in reduced anxiety and depression and improved 
CHF specific HRQoL 173. In one RCT study the intervention was partly composed 
of nurses providing depression care management and an evidence-based problem-
solving treatment for depression over the telephone, which resulted in reduced 
depression and improved problem-solving skills as well as self-efficacy 174. There 
are a few studies that have examined self-management programs tailored at 
behavioural change, or psychosocial self-management skills 175, 176. Improvements 
were found in disease specific HRQoL, however, the results were inconclusive with 
regard to time-duration of the effect. In addition, no effects were found in mental 
functioning, perceived control, self-efficacy, anxiety and depression 175, 176. 
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3 RATIONALE 
CHF is a serious and chronic syndrome with a poor prognosis and symptom burden 
comparable to many cancer diagnoses. CHF imposes a high burden on the health-
care system and caregivers. Patients with CHF experience impaired HRQoL and 
there is a high prevalence of anxiety and depression. Many studies have shown 
adverse outcomes on poor HRQoL as well as anxiety and depression for patients 
with CHF, such as increased mortality and readmission to hospital. Despite these 
detrimental outcomes elucidated in research, the psychosocial aspects of patients 
with CHF are seldom cared for and treated. There is a lack of evidence on how 
psychosocial support and training of psychosocial self-care skills could be provided 
in a systematic manner. The research conducted on self-care management programs 
has focused mainly on the physical aspects of self-care management in patients with 
CHF. Coping and illness perception are important factors for an individual with 
CHF to adjust to his or her life situation and for emotional well-being. Therefore, in 
order to improve emotional well-being in patients with CHF, interventions should 
focus on coping skills and the appraisal of the illness. Coping effectiveness training 
intervention could provide such an approach. 
Since research has highlighted the importance of coping to health outcomes in 
patients with CHF, it is essential to have a reliable and valid measurement model of 
coping strategies that is feasible to use in research as well as in clinical practice.  
Little is known about the pattern and pathways between illness perception, coping 
strategies and emotional well-being in patients with CHF. There is a need to better 
understand these mechanisms in order to identify variables that might be of 
importance in a psychosocial intervention. Furthermore, research on factors that 
might influence the choice of coping strategies, such as illness severity, 
demographic variables as well as sense of coherence, in patients with CHF is 
limited and requires further investigation. There is also limited knowledge of how 
different coping strategies influence positive as well as negative affect considered as 
a main pillar of emotional well-being. 
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4 AIMS OF THE THESIS 
4.1 OVERALL AIM 
To gather scientific evidence regarding the influence of illness perception, coping 
strategies and sense of coherence on emotional well-being in patients with CHF. 
Furthermore, to establish a theoretically and empirically sound measurement model 
of coping strategies. Finally, to develop, implement and evaluate a nurse-led 
psychoeducational intervention for improving patients’ adaptive coping skills, 
appraisal of the illness, emotional well-being, HRQoL and clinical outcomes. 
4.2 SPECIFIC AIMS 
The specific aims of each study were to: 
Investigate whether functional status, demographic variables and sense of 
coherence may be related to the coping strategies used by patients with CHF, and to 
examine how coping strategies may be associated with different dimensions of 
affect, considered as a main pillar of emotional well-being for these patients. (I) 
Examine the structure of Brief COPE, founded on the higher order grouping of its 
subscales, in order to establish an assessment model supported by theoretical 
considerations. Furthermore, to examine the associations between these higher 
order categories of coping and HRQoL in order to establish the predictive validity 
of the selected model in the context of CHF. (II) 
Examine the links between illness perceptions, coping style and anxiety and 
depression, and to examine the potential mediating role of avoidant coping style and 
illness perception on these links in patients with CHF. (III) 
Develop, implement and evaluate a Coping Effectiveness Training (CET) program 
for patients with CHF, with the objective of increasing emotional well-being 
(primary outcome), HRQoL (secondary outcome) and improve clinical outcomes 
(tertiary outcome). Furthermore, the study also aimed to examine changes in 
appraisal of illness burden and control over the illness as well as coping styles as 
potential mediators of the intervention effect. (IV) 
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5 METHODS 
5.1 STUDY DESIGN 
In this thesis a wide range of quantitative methodologies were applied. A cross-
sectional research design was applied in Studies I-III. Study I examined correlations 
and predictions. Study II was a methodological study and Study III tested models of 
mediational relations. In study IV a randomized controlled longitudinal research 
design was carried out in order to evaluate CET intervention in patients with CHF. 
Table 2. Overview of Studies I-IV 
 Study I Study II Study III Study IV 
Design Cross-
sectional 
research 
design 
Methodological 
cross-sectional 
research design 
Cross-
sectional 
research 
design 
Randomized 
controlled 
trial 
Self-
assessment 
questionnaires 
Brief COPE 
PANASa 
SOCb-scale 
Brief COPE 
RAND-36c 
B-IPQd 
Brief COPE 
HADSe 
 
B-IPQ 
Brief COPE 
ESSIf 
HADS 
PANAS 
RAND-36 
Clinical & 
demographic 
measurements 
Age 
NYHA class 
Sex 
Age 
Duration of 
CHF 
NYHA class 
NYHA - 
class 
Readmission 
to hospital 
Mortality 
Age 
Sex 
Sample  n = 80 n = 183 
 
n = 103 n = 103 
a Positive Affect Negative Affect Schedule, b Sense of Coherence, c Research And Development 36-
item health survey, d Brief Illness Perception Questionnaire, e Hospital Anxiety and Depression Scale, 
f ENRICHD Social Support Inventory 
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5.2 STUDY SAMPLE AND SETTING 
5.2.1 Study I 
Participants were enrolled in the study at a heart failure ward and at a nurse-led 
heart failure outpatient clinic at a hospital in Stockholm County Council, Sweden. 
Enrolled patients met the following inclusion criteria: NYHA class II-IV and aged 
over 18 years. The exclusion criteria were: cognitive dysfunction, life threatening 
disease such as cancer or primary organ failure and not being able to understand the 
Swedish language. In total 143 patients were asked by the research nurse to 
participate in the study and 94 accepted to join. Fourteen participants were excluded 
owing to an incomplete response or no response at all. Consequently, 80 
participants were included in Study I. 
5.2.2 Study II-IV 
Participants were included from a waiting list at a nurse-led heart failure outpatient 
clinic at a hospital in Stockholm County Council, Sweden. The following inclusion 
criteria were applied: classified as NYHA class II-III and aged over 18 years. The 
exclusion criteria were: cognitive dysfunction, a life threatening disease such as 
cancer or primary organ failure and/or a severe psychiatric diagnosis such as 
psychosis or severe depression, and not being able to understand the Swedish 
language. A total of 103 patients accepted to join the study. In Study II the study 
sample was merged with the sample in Study I (n = 80) hence a total of 183 
participants were included in Study II. In Study III and Study IV the study sample 
consisted of 103 participants. 
5.3 PROCEDURE 
5.3.1 Study I-III 
The participants filled in self-assessment questionnaires at one time point after 
accepting to join the studies (I-III). In Study I the participants could choose to fill in 
the self-assessment questionnaires at the hospital or at home. Pre-stamped, 
addressed envelopes were handed out together with the questionnaires. Reminders 
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were sent out to the participants after two and four weeks in Study I and after one 
and two weeks in Studies II-III. 
5.3.2 Study IV 
Random allocation sequences were generated in Excel® (Microsoft, Redmond, WA, 
USA) in blocks of 30 by the principal supervisor. The author and the principal 
supervisor prepared sealed envelopes containing a paper stating the allocated 
randomization group. Afterwards the envelopes were randomly mixed and a 
number according to the random number sequence was written on the envelope.  
Eligible patients were either informed verbally, and given written information at the 
outpatient clinic, or were sent written information by post to their home with a 
follow-up telephone call one week later to provide verbal information. After 
accepting to join the study the participants were given self-assessment 
questionnaires that they filled in at home and returned by post. The number on the 
self-assessment questionnaires was noted with the participant’s social security 
number and name. The participants were enrolled mainly by the author and some by 
colleagues at the nurse-led heart failure outpatient clinic. The colleagues had 
received both written and oral information about the study procedure. After the 
baseline measurement was completed and returned, the author opened the sealed 
envelope corresponding to the number on the baseline measurement and the 
participants were randomized in to one of two arms; control group (CG) or 
intervention group (IG). Specific information about allocation to randomization 
groups was posted to the participants' homes. 
The self-assessment questionnaires were sent out again by post at: post-
intervention, six weeks, six months and twelve months after the intervention to both 
randomization groups. Reminders were sent after one and two weeks, and after 
three weeks a phone call was made to those who had not yet returned the 
questionnaires. In addition, an anonymous written evaluation form was filled in by 
the participants in the IG directly after finishing the CET. The enrolment and flow 
of study participants throughout Study IV are displayed in Figure 3. The enrolment 
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process took two and a half years between 2010 and 2013. The trial has been 
registered at ClinicalTrials.gov: NCT02463903. 
Figure 3. Flow chart of screening, enrolment, randomization and follow-up of participants 
in Study IV. The randomized participants, n = 103, were included in Study II and Study III. 
Number of people analysed in Study IV is stated for the Repeated measures ANCOVA. In 
the survival analysis n = 44 in the intervention group and n = 50 in the control group were 
analysed. (The figure is from Paper IV in this thesis.) 
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5.3.2.1 Control group 
The participants in the CG received standard health care for patients with CHF such 
as: nurse-led heart failure outpatient clinic, cardiology specialist outpatient or 
primary health care. 
5.3.2.2 Intervention group 
Apart from standard health care the participants in the IG also received CET, a 
manual-based group intervention. The CET intervention is based on Lazarus and 
Folkman’s theory of stress and coping 115. CET has previously been applied to other 
patient groups with serious chronic conditions, such as HIV and spinal cord injury 
(SCI), and showed positive results 177, 178. The purpose of the CET was to improve 
participants' skills to appraise stress, to teach a number of techniques to cope with 
stress, and to provide an opportunity to interact with other people living with CHF. 
The participants received seven 90 minute CET sessions weekly and a workbook 
with a brief summary and goals of every session, as well as home assignments. 
Table 3 displays the theme for each session. The groups were led by the author of 
this thesis, a cardiac nurse specialized in CHF with more than 10 years experience, 
who received supervision by a psychologist the fifth author in Study IV. The first 
group was jointly led by the nurse and the psychologist and subsequent groups by 
the nurse alone. After each CET session the nurse received supervision from the 
psychologist. In total there were five intervention groups with 7-12 people in each 
group. The sessions were held in a conference room at the author’s institution. Both 
the workbook and the manual were translated from English in to Swedish and 
adapted for patients with CHF from Kennedy’s original books applying CET for 
patients with SCI 179, 180, by the author of this thesis and the fifth author in Study IV. 
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Table 3. Themes for each CET session. 
Session Theme 
1 Introduce the concept of stress and coping. Identify individual stress 
reactions. 
2 Identify stress evoking appraisals. Introduce coping strategies. Break 
down stressful situations into manageable parts. 
3 Explain problem focused coping. Practice a structured problem 
solving method. 
4 Explain emotion focused coping. Practice relaxation training. 
Scheduling positive activities to counteract negative thoughts. 
5 Challenging negative thoughts. Discuss negative automatic thinking 
and common thinking errors. 
6 Discuss adaptive and maladaptive coping and identify such personal 
coping strategies. 
7 Present different kinds of social support and discuss how social 
support can reduce stress, facilitate problem solving and generate 
positive emotions. 
 
5.4 DATA COLLECTION 
5.4.1 Demographic and clinical data 
In all the studies, demographic data were filled in by the participants on a form 
together with the self-assessment questionnaires that were handed out after they had 
accepted to participate. Clinical background data were gathered via the participants’ 
medical journals by the author of this thesis. In Study IV clinical outcome 
measurements of rehospitalization and death as well as total time for inpatient care 
were obtained from a central regional database at the Stockholm County Council. 
Time to death and hospitalizations cardiovascular cause and all cause were 
measured during the entire follow-up period (median 35 months, IQR 11 months). 
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5.4.2 Self-assessment questionnaires 
5.4.2.1 Brief COPE (Study 1-IV) 
To measure coping strategies Brief COPE was utilized 144. Brief COPE is a shorter 
version of the 60-items COPE inventory 119 thus relieving some of the respondent 
burden. Brief COPE has 28 items and measures 14 coping strategies: Active 
Coping, Planning, Positive Reframing, Acceptance, Humour, Religion, Using 
Emotional Support, Using Instrumental Support, Self-Distraction, Denial, Venting, 
Substance Use, Behavioural Disengagement, and Self-Blame. Each coping strategy 
is indicated by two items. The respondent is asked to think about the following: 
What do you usually do when you are stressed by a problem? The 28 items consist 
of statements such as “I try to come up with a strategy about what to do”. Each 
statement is graded on a 4-point Likert scale: 1 = Very seldom, 2 = Fairly seldom, 3 
= Fairly often, 4 = Very often. Higher sum score of each subscale indicate greater 
utilization of the coping strategy. Brief COPE has proven to be a reliable and valid 
measurement of coping styles and has been used in research with a heart failure 
population showing good internal consistency 130. The Swedish version of Brief 
COPE has been psychometrically tested and proved to have adequate properties 181.  
5.4.2.2 Brief Illness Perception Questionnaire (B-IPQ) (Study III, IV) 
B-IPQ measures illness perception and consists of nine items 182. B-IPQ was 
developed from the 80-item IPQ 147 and IPQ-R 183. The short form was used 
because it could be more suitable for severely ill or elderly people, as it reduces 
respondent burden. Of the nine items, eight new items were developed to mirror 
each subscale in IPQ-R, one item summarising each subscale 182. Five items assess 
cognitive representations; consequences, timeline, personal control, treatment 
control and identity. One item assesses illness comprehensibility. Two items assess 
emotional representations: concern and emotions. The last item is an open ended 
question and assesses casual representation by asking the respondent to list three 
reasons that could have caused the illness. Each subscale is indicated by one item. 
The rating scale of the first eight items ranges from 0 to 10 on a unipolar scale with 
verbal labels on each side of the scale. Higher scores indicate a more threatening 
view of the illness, except for the two items that measure control where higher 
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scores indicate greater control. The psychometric properties of B-IPQ have been 
tested in several patient groups, including cardiac patients and have shown good 
reliability and validity 182. Previous research has used B-IPQ in patients with CHF 
154. 
5.4.2.3 ENRICHD Social Support Inventory (ESSI) (Study IV) 
ESSI was developed for the Enhancing Recovery in Coronary Heart Disease 
Patients (ENRICHD) trial 184. ESSI consists of seven self-assessed items where the 
first six items measure four components of social support: emotional, instrumental, 
informational and appraisal support 185. The items in ESSI derive from items from 
other social support instruments that have been found to be individually predictive 
of death in cardiac patients 184. These items are represented by statements such as: 
“Is there someone available to you who shows you love and affection?” and are 
rated on a five point Likert scale rating from never to always. The seventh item 
concerns marital status. A higher total sum score indicates greater social support. 
ESSI has been validated in cardiac patients 185, 186. ESSI has, within the current 
doctoral project, been translated to Swedish, using forward and backward 
translation, expert group and cognitive interviewing with think-aloud protocol 187. 
5.4.2.4 Hospital Anxiety and Depression Scale (HADS) (Study III, IV) 
HADS is a 14-item questionnaire that measures anxiety and depression 188. Seven 
items represent anxiety and seven items represent depression. Each item has four 
answers to choose from and the answers are scored from 0-3. The subscales of 
anxiety and depression can have scores ranging from 0-21 where a higher score 
indicates greater anxiety and depression. A cut-off point of ≥ 11 has been suggested 
for definitive clinical cases of anxiety and depression 188. HADS was intended for 
medically ill patients and does not take clinical symptoms of anxiety and 
depression, such as heart palpitation and fatigue, into account as these symptoms 
might also indicate a medical condition 188. The Swedish version of HADS has been 
psychometrically tested and proven to be a reliable and valid clinical indicator for 
anxiety and depression 189. HADS has been used in heart failure populations, 
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showing good reliability and prognostic value 87, 130 and is well-established in 
cardiac patients 190. 
5.4.2.5 Positive Affect Negative Affect Schedule (PANAS) (Study I, IV) 
PA and NA are measured with the 20-item PANAS 73, which is a self-assessment 
questionnaire consisting of 20 adjectives describing different emotions. Ten items 
assess PA e.g. interested, enthusiastic and alert, and 10 items assess NA e.g. 
ashamed, hostile and upset. The main question was; “Please state to what extent you 
have felt this during the past four weeks.” The items are rated on a 5-point Likert 
scale: 1 = not at all, 2 = a little, 3 = moderately, 4 = quite a bit, 5 = very much. 
Higher sum scores on the two subscales indicate greater PA and NA. The reliability 
and validity of PANAS has been tested and found to have good psychometrical 
properties 73, 191. PANAS has demonstrated good internal consistency in research 
involving patients with CHF 58, 192.  
5.4.2.6 RAND 36-item Health Survey 1.0 (Study II, IV) 
The RAND 36-item Health Survey 1.0 is a generic profile, self-reported instrument 
of HRQoL and includes eight subscales; physical functioning, role limitation due to 
physical health, role limitation due to emotional problems, energy/fatigue, 
emotional well-being, social functioning, bodily pain and general health. A single 
item also measures perceived change in health during the past year 193. The items 
are identical to the ones in the Medical Outcomes Study (MOS) 36-item short form 
health survey (SF-36) 194 but the scoring is somewhat different. Scoring is done by 
recoding the items between 0 and 100, where a higher score indicates a better health 
condition. The items are averaged to create each scale and missing data are not 
taken into account, so the average represents the items actually responded to in each 
scale. RAND 36 has also been suggested to consist of two health summary scores; a 
physical and a mental health composite. The physical health composite derives 
from the subscales: physical functioning, role limitation due to physical health, 
bodily pain and general health. The mental health composite derives from the 
subscales: role limitation due to emotional problems, emotional well-being, social 
functioning and energy/fatigue 195. RAND 36 has shown good psychometric 
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properties 196 and has been used in many studies for measuring HRQoL in patients 
with CHF 197-199. 
5.4.2.7 Sense of Coherence (SOC)-scale (Study I) 
For assessing SOC the shorter 13-item SOC-scale was used, which originates from 
the 29-item SOC-scale 200. The SOC-scale measures three components of SOC: 
comprehensibility, manageability and meaningfulness. Each item is rated on a 
unipolar scale ranging from 1-7 with two anchoring responses e.g. never and very 
often. An item can be phrased like; “How often do you have the feeling that there’s 
little meaning in the things you do in your daily life?” Some item scores are 
reversed before the total sum score can be calculated. The possible total score 
ranges from 13 to 91 where a higher score indicates a stronger sense of coherence. 
The SOC-scale has been proved to possess good psychometrical properties 
worldwide 201. The Swedish version of the 13-item SOC-scale has been found to be 
reliable and valid 202 and has been utilized to measure SOC in individuals with CHF 
in Sweden 167. 
5.5 DATA ANALYSIS 
A summary of the data analysis is given in this section. Studies I and IV used 
general linear models (GLM) 203 and Studies II and III used structure equation 
modelling (SEM) 204 in the main analysis. Detailed descriptions of the statistical 
analyses performed in the studies can be found in each individual Study paper. 
Table 4. Overview of the statistical analyses employed in each study. 
Study I Study II Study III Study IV 
Student’s t-test. 
Mann-Whitney U-
test. 
Pearson and 
Spearman 
correlation analysis. 
Multiple linear 
regression analysis. 
Confirmatory 
Factor Analysis. 
Pearson 
correlation 
analysis. 
Hierarchical linear 
regression 
analysis. 
Path-analysis. 
Mediation 
analysis. 
Pearson 
correlation 
analysis. 
Chi-square test. 
Fisher’s exact test. 
Student’s t-test. 
Repeated Measures 
and Mixed ANCOVA. 
Univariate ANOVA. 
Kaplan-Meier. 
Cox regression. 
Mann-Whitney U-test. 
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5.5.1 Study I 
Statistical analyses were carried out with the statistical software IBM Statistical 
Package for Social Sciences (SPSS) Statistics version 16 for Windows (SPSS inc, 
Chicago, IL, USA). Differences in the choice of coping strategies between NYHA 
classes II and III and gender groups were analysed with Student’s t-test for 
normally distributed data or Mann-Whitney U-test for variables departing from 
normality (religion and substance use). For the purpose of examining the 
associations between age and SOC with coping strategies Pearson correlation and 
the non-parametric Spearman correlation analyses were performed. Furthermore, in 
order to examine the associations between SOC and higher order grouping of 
coping strategies with PA and NA, correlation analyses were carried out. Variables 
that showed significant correlations with PA and/or NA in the latter analyses were 
included in regression analyses with the aim of examining the predictive value for 
PA and NA. 
5.5.2 Study II 
IBM SPSS Statistics version 22, SPSS Amos version 22 (IBM corp. Armonk, NY, 
USA) and Mplus version 7.1 (Muthén & Muthén, Los Angeles, CA, USA) were 
used to perform the statistical analyses in Study II. In order to evaluate different 
proposed higher structure models of Brief COPE, Confirmatory Factor Analyses 
(CFA) with maximum likelihood estimation were performed. The following model 
fit indices were applied: Chi-square test statistics, Comparative Fit Index (CFI), 
Root Mean Squared Error of Approximation (RMSEA) and Standardized Root 
Mean square Residual (SRMR). For comparison between nested models the 
likelihood ratio test (LRT, Δχ2) 205 was utilized. For examining theoretically 
justifiable modifications to improve fit of acceptable models, Modification Indices 
(MI) were inspected. The following six models of Brief COPE were included in 
CFA: two 2-factor models 130, 145, one 3-factor model 146 and three 4-factor models 
where one of the models was from Study I 119, 206, 207.  
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The predictive validity of the best fitted higher order structure of Brief COPE was 
investigated with hierarchical linear regression analysis, with measures of physical 
and mental health composites in the RAND 36-item Health Survey 1.0 193 as 
dependent variables. In the first block age, NYHA class and duration of CHF 
(dichotomized in < or ≥ 6 months) were entered and in the second block the higher 
order categories of coping strategies in Brief COPE were entered, together with the 
significant predictors in the first block as independent variables. 
5.5.3 Study III 
Statistical analyses were performed with IBM SPSS Statistics version 22, SPSS 
Amos version 22 and Mplus version 7.2. The mediation analyses were founded on 
Baron and Kenny’s 208 and MacKinnon’s 209 recommendations on steps in 
mediation analysis, and were extended to include multiple mediators. The 
hypothesized mediation models were constructed based primarily on two different 
theoretical assumptions; the theory of self-regulation 148 and the theory of 
dispositional coping 121. If a hypothesized mediator, either domains of illness 
perception or avoidant coping, could not be regressed on a predictor, and/or if the 
outcomes could not be regressed on the mediator, the mediation hypothesis was 
discarded 208, 209.  
5.5.4 Study IV 
Statistical analyses were carried out using IBM SPSS Statistics version 22 (IBM 
corp. Armonk, NY, USA). A power analysis was calculated based on PANAS with 
a moderate effect size of Cohen’s d = 0.50 and alpha = 0.05, indicating that to 
obtain a power of 0.80 a sample size of 72 patients was required. To account for 
drop-outs another 15 participants were added to each arm to ensure an adequate 
sample size. 
The primary analysis was performed with intention to treat (ITT) and the secondary 
analysis with per protocol (PP). Analysis with ITT included participants that 
attended at least one CET session, as no follow-up data were obtained from those 
who dropped out before the start of the intervention. In the analysis with PP 
attending five or more CET sessions was regarded as completing the CET. 
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The primary and secondary outcomes were analysed with a 2 x 4 mixed design 
(Intervention x Time) ANCOVA with the baseline assessments of each dependent 
variable included as a covariate. Follow-up analyses to significant treatment main 
effects were carried out by univariate ANOVA and effect size was described with 
Cohen’s d. In order to exclude clinical cases of anxiety and depression the analyses 
were performed amongst cases with a cut-off value on HADS < 11 188. Finally, the 
analyses were replicated with adjustment for social support. 
To evaluate the tertiary outcome, Kaplan-Meier analyses were performed on time 
from start of the intervention to cardiovascular and all cause readmission to hospital 
or death. Hazard ratio (HR) was analysed with Cox regression adjusted for age and 
sex. Total time for inpatient care was analysed with Mann-Whitney U-test.  
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6 ETHICAL CONSIDERATIONS 
Research involving human beings should be conducted in accordance with the 
international ethical guideline Declaration of Helsinki 210. The guiding principles 
highlight, for example, beneficence, protection of vulnerable groups, informed 
consent and confidentiality which were considered during the whole process of this 
doctoral research project. 
The four studies were approved by the Regional Ethics Review Board at Karolinska 
Institutet, Stockholm Dnr 2007-1302-31/2 (Study I), Dnr 2010/1867-31/5 and 
amendment Dnr 2011/1132-32 (Studies II-IV).  
All research participants were given verbal and written information about the study 
before giving their acceptance to participate. The written information explained: the 
purpose and procedure of the study, assurance of patients’ confidentiality, voluntary 
participation and the right to withdraw from the study at any time without giving a 
reason. It was made clear that non-participation would not influence the patients’ 
future health care. Contact information for the research group was also given. 
Eligible patients were given time to consider before deciding to accept or not. 
Patients with CHF could be considered to be a vulnerable group, therefore, attention 
was given to signs of doubt so not to apply pressure on patients to participate. The 
patients who accepted to participate signed an informed consent and were given a 
copy of the document. For some eligible patients the author of this thesis was also 
the treating nurse at the heart failure outpatient clinic. However, none of the 
participants were a patient of the author at the same time as the intervention was 
being held.  
All data were coded and a code list was kept in a secure location in order to ensure 
confidentiality. The results from the studies were presented on a group level so that 
no individual identities were revealed. 
There was no risk of physical harm to any participants in the studies. Contact 
information for the researchers was given in case of any questions that might arise 
when, for example, answering the self-assessment questionnaires that might be 
experienced as difficult or sensitive to answer. Special consideration was taken to 
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reduce respondent burden when choosing the self-assessment questionnaires for the 
studies, which is why some of the self-assessment questionnaires were a shorter 
version of the original. Answering the questions could be regarded as beneficial, in 
that it allowed time for reflection by participants. 
Potential benefits for the intervention group, participating in Study IV, could be the 
positive effects of the intervention itself. The participants randomized to the control 
group might have been disappointed. Clear information was given prior to 
acceptance to participate that the participants would be randomized. Only one 
participant randomized to the control group stated that the allocation was the reason 
for declining further participation in the study. On the other hand, the participants in 
the control group may still have felt that they were contributing to development, 
implementation and evaluation of a psychoeducational intervention for patients with 
CHF.  
When the Coping Effectiveness Training groups were formed in Study IV 
information was given at the start about the rule of confidentiality within the group. 
That is, experiences and opinions shared in the group during the sessions would stay 
within the group. 
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7 RESULTS 
The results are presented in a logical, rather than chronological, order as follows: 
factors that might influence coping strategies, a model for measuring coping 
strategies, the influence of coping strategies on different outcomes in emotional 
well-being and HRQoL and finally the evaluation from the CET intervention. 
Clinical and demographic data of the participants can be found in each individual 
Paper. 
7.1 LINKS BETWEEN NYHA CLASS, AGE, GENDER AND SOC WITH 
COPING 
The hypothesised association between functional status, NYHA class and coping 
strategies used by individuals with CHF was not confirmed in Study I. No 
significant differences between NYHA class II and III were found. The 
demographic variables, age and gender, included in the hypothesis did not show any 
significant differences or associations with coping strategies except for one; 
substance use. Men had a significantly higher mean rank score than women (Mann–
Whitney U = 428.5, p < 0.01) for substance use. Furthermore, there was a negative 
significant correlation with age for substance use (ρ = −0.35, p < 0.01). Total score 
of SOC had significant negative correlations with the coping strategies venting, r = 
−0.35, p < 0.01, and self-blame, r = −0.40, p < 0.01. 
7.2 A FOUR-FACTORIAL MODEL FOR MEASURING COPING 
STRATEGIES  
Analyses of the Brief COPE models with CFA in Study II revealed poor model fit 
indices for the two-factor models and the three-factor model. The four-factorial 
model of Brief COPE presented by Perez et al. 127 showed improved but not 
satisfactory model fit statistics. When constructing a model of Brief COPE, based 
on the original COPE generating a four-factorial structure, acceptable fit statistics 
were approached with the exception of RMSEA 211. The four-factorial model of 
Brief COPE suggested by Nahlén et al. 207 in Study I in this thesis was found to 
have fairly good model fit indices. Examining MI for the four-factor model 
proposed in Study I revealed that the model was further improved if the error 
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variance for planning, emotional support and instrumental support were allowed to 
co-vary. The improvement of the fit statistics of this model on the basis of these 
modifications was further supported by the LRT (Δχ2 = 21.24, df = 2; p < 0.001). 
The model with the different components for each higher order coping factor, is 
displayed in Figure 4. 
Figure 4. The modified four-factor model of Brief COPE that showed the best psychometric 
properties. (The figure is from Paper II, published in Cardiology Research.) 
 
7.3 COPING AND OUTCOMES IN EMOTIONAL WELL-BEING AND 
HRQOL 
7.3.1 Positive and negative affect 
In Study I, correlations between coping strategies and different dimensions of affect 
were examined. Active coping, positive reframing, and emotional support 
correlated significantly with PA (p < 0.01). Venting, behavioural disengagement, 
substance use and self-blame correlated significantly with NA (p < 0.01). 
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Correlations with PA and NA were furthermore explored with the four-factor model 
of Brief COPE as well as SOC. 
The variables that significantly correlated with PA and NA were included as 
predictors in regression analysis for PA and NA (Table 5). Problem focused coping 
significantly predicted PA, however, the total variance explained by this regression 
analysis was limited to 14%. Avoidant coping, socially supported coping and SOC, 
significantly predicted NA and accounted for 31% of the total variance in this 
dimension of affect. 
Table 5. Regression analysis of Positive Affect (PA) and Negative Affect (NA). Each 
dimension of affect is a dependent variable regressed separately on its predictors. (The table 
is from Paper I, permission from the publisher has been retrieved.) 
Independent variable                                Standardised betas (β)                               t           
Dependent variable: PAa                                       
  Problemfocused coping                                     .28                                              2.13* 
  Socially supported coping                                 .13                                              0.96 
r² = 0.14, F(2,77) = 6.00, p < 0.01 
Dependent variable: NAb 
  Avoidant coping                                                .26                                              2.53* 
  Socially supported coping                                 .24                                              2.47* 
  SOCc total                                                         -.32                                            -3.23** 
r² = 0.31, F(3,76) = 11.58, p < 0.001 
* p <.05, ** p <.01, a Positive Affect, b Negative Affect, c Sense of Coherence 
7.3.2 Depression and anxiety 
In Study III, two hypothesised pathways for coping, illness perception and 
emotional distress were examined.  
The mediation model based on Leventhal’s theory could not be confirmed with the 
data in the study where avoidant coping was a mediator between illness perception 
and emotional distress. The hypothesised model, where illness perception was a 
mediator between avoidant coping and anxiety and depression, was found to have 
good model fit indices (χ² = 13.52, df = 9 p = 0.14, CFI = 0.981, RMSEA = 0.072 
90 % CI = 0.000 – 0.145, SRMR = 0.047). The influence of Avoidant coping on 
depression was partly mediated by Identity and Personal control and the influence 
of Avoidant coping on Anxiety was in part mediated by Identity. This mediation 
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model explained 47 percent of the variance in Anxiety and 36 percent of the 
variance in Depression (Figure 5). 
Figure 5. Final mediation model with items from B-IPQ as mediators between Avoidant 
coping and Anxiety and Depression. The illness perception items Personal control and 
Treatment control are reversed, meaning higher score indicate lower sense of control. The 
displayed path coefficients are unstandardized (B) and the values in brackets display bias 
corrected 95 % confidence intervals (CI). (The figure is from Paper III in this thesis.) 
 
7.3.3 HRQoL  
In Study II, the four higher order groupings of coping in Brief COPE were 
examined as predictors of both the physical and mental composite of RAND 36 in 
order to establish the predictive validity of the proposed four-factor model. 
Avoidant coping and NYHA class significantly inversely predicted both physical 
(F(6) = 4.61, P < 0.001) and mental aspects (F(6) = 11.36, P < 0.001) of HRQoL 
when controlled for age. Problem focused coping, emotion focused coping and 
socially supported coping did not predict outcomes in HRQoL. The model in the 
hierarchical multiple regression analysis explained 26 % of the variance of the 
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physical health composite, and the corresponding explained variance for the mental 
health composite was 40%. 
7.4 EVALUATION OF A COPING EFFECTIVENESS TRAINING 
INTERVENTION  
In Study IV, evaluation of the CET intervention was carried out with Patient 
Reported Outcome Measures (PROM) and clinical outcome measures. Additional 
results from an evaluation with Patient Reported Experience Measure (PREM) are 
also presented. There were no statistically significant differences between the 
baseline characteristics of the two randomization groups or between participants 
lost to attrition (n = 8) and those who received the intervention (n = 44) and 
between those who completed the intervention (n = 35) compared to non-
completers (n = 9).  The attendance rate at the CET intervention was good, where 
80 percent attended five or more CET sessions (Figure 6). 
Figure 6. The attendance rate of the CET intervention, n = 44. 80 percent attended 5 or 
more CET-sessions. 
 
7.4.1 Patient reported outcomes 
The PROMs were PANAS, HADS, RAND 36, B-IPQ, Brief COPE and ESSI. 
2 4 1 2
7
17
11
1 2 3 4 5 6 7
N
um
be
r o
f p
ar
tic
ip
an
ts
Number of sessions
Attendance rate at the CET-intervention
  43 
7.4.1.1 Emotional well-being and HRQoL (primary and secondary outcome) 
In the primary outcome, lower average mean scores were shown for NA, anxiety, 
depression as well as higher average mean scores for PA. In the secondary outcome, 
higher average mean scores were found for the physical and mental component of 
RAND 36 for the IG (Table 6). However, these average mean score differences in 
the primary and secondary outcomes between the IG and CG did not render 
statistical significance (range of p = 0.108 - 0.595). 
After excluding clinical cases of anxiety and/or depression (n = 6 in IG and n = 10 
in CG) a significant main intervention effect was found for NA F(1,46) = 5.60, p = 
.022, Cohen’s d = 0.64. Univariate analyses revealed that those who completed the 
intervention had significantly lower NA at post-intervention F(1,59) = 4.24, p = 
.044 and at 6-months follow-up F(1,57) = 4.62, p = .036. 
Table 6. Results of the CET intervention on primary and secondary outcome measures. 
Mean and standard deviation (SD) of the four follow-ups and average mean scores for 
intervention group and control group. Between-group effect of Repeated measures 
ANCOVA. 
  Postintervention 6 weeks 6 months 12 months Average 
Between-
subject  
Outcomes            
(min-max) IGa CGb IG CG IG CG IG CG IG CG 
F p 
Anxiety                  
(0-21) 
4.37 
(4.27) 
4.50 
(3.57) 
4.54 
(4.35) 
4.78 
(4.28) 
3.97 
(4.19) 
4.40 
(3.75) 
4.17 
(3.72) 
4.77 
(4.23) 
4.26 
(4.13) 
4.61 
(3.96) 0.50 .483 
Depression              
(0-21) 
4.51 
(3.66) 
5.00 
(3.69) 
4.26 
(3.02) 
5.33 
(4.41) 
4.60 
(3.64) 
5.13 
(3.92) 
4.29 
(2.96) 
5.15 
(4.00) 
4.42 
(3.32) 
5.15 
(4.01) 0.44 .511 
PAc               
(10-50) 
31.61 
(8.10) 
30.47 
(8.35) 
31.35 
(7.58) 
30.28 
(7.83) 
30.65 
(7.76) 
30.36 
(8.96) 
30.68 
(8.15) 
31.31 
(7.60) 
31.07 
(7.90) 
30.61 
(8.19) 2.65 .108 
NAd             
(10-50)  
15.63 
(6.52) 
17.62 
(6.04) 
16.43 
(6.32) 
18.03 
(7.34) 
15.93 
(5.87) 
17.95 
(5.82) 
17.03 
(7.29) 
17.59 
(5.89) 
16.26 
(6.50) 
17.80 
(6.27) 1.29 .260 
PHCe                 
(0-400) 
241.59 
(84.61) 
218.69 
(94.25) 
239.87 
(88.03) 
211.25 
(102.63) 
235.61 
(91.32) 
211.11 
(96.29) 
237.80 
(94.93) 
233.59 
(101.05) 
238.72 
(89.72) 
218.66 
(98.56) 0.57 .452 
MHCf           
(0-400) 
272.37 
(88.32) 
264.11 
(93.77) 
265.50 
(90.04) 
259.60 
(95.81) 
271.30 
(78.80) 
259.67 
(90.68) 
265.35 
(94.72) 
262.76 
(102.00) 
268.63 
(87.97) 
261.54 
(95.57) 0.29 .595 
a Intervention group, b Control group, c Positive Affect, d Negative Affect, e Physical Health Composite 
of RAND 36, f Mental Health Composite of RAND 36 
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7.4.1.2 Illness perception and coping 
A main intervention effect was found for the appraisal of having personal control 
over the illness F(1,74) = 4.56, p = .036, Cohen’s d = 0.36. The results from the 
univariate ANOVA showed a greater personal control in the IG at 6-week follow-
up F(1,81) =  4.72, p = .033. The results were further confirmed in the analysis with 
PP with a main intervention effect F(1,68) = 8.19, p = .006, Cohen’s d = 0.49 and 
significance at 6-week follow-up F(1,74) = 6.69, p = .012.  
With regard to coping styles, no main intervention effects were detected between 
the two randomization groups (range of p 0.249 - 0.542). A significant interaction 
effect was shown in emotion focused coping F(3,204) = 2.83, p = .040. The IG had 
greater emotion focused coping up until 6 weeks and afterwards the CG increased 
emotion focused coping whereas it decreased in the IG. 
7.4.1.3 Social support 
When replicating the analysis adjusted for social support no new findings were 
found and the significant results revealed in the primary and secondary analyses 
remained. 
7.4.2 Clinical outcomes 
The tertiary outcome, readmission or death and total inpatient time from 
cardiovascular cause or all causes, were found to be non-significant between the 
randomization groups. Time to cardiovascular readmission or death were non-
significantly lower in IG vs CG (HR 0.58 [0.29-1.18, p = 0.135]) adjusted for age 
and sex as seen in Figure 7. 
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Figure 7. Kaplan-Meier curve for time to first cardiovascular readmission or death, with 
adjusted hazard ratio (HR) for age and sex. (The figure is from Paper IV in this thesis). 
 
7.4.3 Patient reported experience 
After completing the intervention the participants (n = 33) filled in an anonymous 
written evaluation form of CET, which consisted of both closed and open-ended 
questions. The reported experience indicated that most of the participants 
considered they benefited from the intervention (94 %) and that they would 
recommend it to a friend (97 %). The participants’ expectations before starting the 
CET varied between small (65 %) and great (45 %). The majority were pleased with 
the number (81 %) and length (79 %) of the sessions as well as the number of group 
participants (73 %). The free-text answers gave insight into what they explicitly 
thought they benefited from, such as the means to cope with CHF, acceptance of the 
illness and meeting other people with the same problems. 
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8 DISCUSSION 
8.1 GENERAL DISCUSSION 
The overall aim of this thesis was to gather scientific evidence regarding the 
influence of illness perception, coping strategies and sense of coherence on 
emotional well-being in patients with CHF. Furthermore, to establish a theoretically 
and empirically sound measurement model of coping strategies. Finally, to develop, 
implement and evaluate a nurse-led psychoeducational intervention for improving 
patients’ adaptive coping skills, appraisal of the illness, emotional well-being, 
HRQoL and clinical outcomes. 
8.1.1 Influence of age, gender, NYHA class and SOC on coping 
In Study I it was hypothesized that NYHA class, age, gender and SOC would be 
associated with coping strategies used by patients with CHF. The hypothesis was to 
some extent confirmed mainly by negative associations via SOC and maladaptive 
coping strategies such as venting and self-blame. That is, the less an individual 
views their life situation as meaningful, comprehensible and manageable, the more 
likely the individual is to engage in these maladaptive coping strategies. This 
association has not previously been elucidated in patients with CHF, but similar 
results have been found in other groups of patients living with chronic illness 212, 213. 
The result confirms the theoretical notion that SOC is a personal internal resource 
against life stressors 162, such as living with CHF. In contrast, the result only 
partially supports Moos and Holahan’s framework of coping with chronic illness, 
where also factors such as illness severity and demographic characteristics are 
proposed to influence the coping process 123. The findings in Study I indicate that 
internal resources play an important role, rather than functional status and 
demographic factors, in how individuals with CHF cope with and adapt to their life 
situation. 
8.1.2 Measurement model for assessing coping styles 
Since different coping strategies have shown associations with adverse health 
outcomes in patients with CHF 14, 127, 133 it is important to have a reliable and valid 
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measurement instrument of coping that is also feasible to use in both research and 
clinical practice. Consequently, Study II aimed at examining higher order structures 
of a coping self-assessment instrument that has been widely used in patients with 
CHF, namely Brief COPE 144. This unique and thorough examination revealed a 
four-factorial structure of Brief COPE, utilized in Study I, to possess the most 
adequate psychometric properties consisting of problem focused coping (active 
coping and planning), avoidant coping (denial, behavioural disengagement and 
substance use), socially supported coping (using instrumental support, using 
emotional support and venting) and emotion focused coping (positive reframing, 
acceptance, humour and religion). This four-factorial model of Brief COPE, utilized 
in Study I, derives from a higher order structure of COPE suggested by Carver et al. 
119. The higher order coping factors in the four factorial model of Brief COPE are 
supported by theoretical assumptions. Problem focused coping and emotion focused 
coping have been theoretically defined by Lazarus and Folkman’s theory of stress 
and coping 115. Carver et al. separated coping strategies generally viewed as 
maladaptive from the emotion focused coping factor and hence the avoidant coping 
factor was generated 119. Carver et al. also suggested a socially supporting coping 
factor 119. The dimensions of socially supported coping are, to some extent, 
supported by a conceptual framework of social support including instrumental 
support, emotional support, tangible support and appraisal support. The findings 
from Study II provide empirical support to the theoretically underpinned four-
factorial model of Brief COPE in the context of CHF. 
8.1.3 Influence of coping styles on emotional well-being and HRQoL 
The findings in this thesis indicates that greater use of avoidant coping worsens 
negative affectivity (Study I), depression, anxiety and malignant illness perception 
(Study III) as well as worsens HRQoL (Study II). Using avoidant coping means that 
an individual avoids thinking about a problem by denying it or constantly 
distracting him or herself from it with activities or by using substances. In this way 
an overwhelmingly stressful situation can be managed and the individual feels 
protected from the stressor 214. CHF, in the light of its chronicity and poor prognosis 
15, could be seen as such an overwhelming stressor where the patient may resort to 
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avoidant coping to protect him or herself. In contrast, long term use of avoidant 
coping is more likely to be harmful than protective 215. The findings in this thesis 
are supported by empirical research on avoidant coping in the context of CHF 
demonstrating adverse outcomes in emotional well-being and HRQoL 14, 130, 132. 
Given the substantial evidence of the maladaptive nature of avoidant coping style in 
individuals with CHF, efforts should be implemented to identify patients who use 
this approach to deal with everyday life. Assessment with the four-factor model of 
Brief COPE (Study II) could be one such approach. 
Besides the salient adverse influence of avoidant coping on emotional well-being 
and HRQoL in patients with CHF, this thesis presents some evidence of the 
influence of other coping styles on emotional well-being. In Study I, problem 
focused coping predicted positive affectivity, that is, if the individual engages in 
planning to actively solve a problem the individual will also feel better. For 
example, the individual with CHF might plan to divide one task across several days 
instead of doing it all on one day and as a result feel less pressure and save energy. 
There is some support for this finding in former research, indicating that problem 
focused coping has favourable effects on emotional well-being 126, 216 and daily 
activities, thus providing a sense of control 135. 
Somewhat unexpectedly, socially supported coping was found to predict negative 
affect although it was significantly correlated to both positive and negative affect. 
This result is inconsistent with previous research 126, 217, however, a qualitative 
study found social support to both interfere and assist in coping with CHF 218. A 
possible explanation for the result in this thesis might be explained by the inclusion 
of venting in the socially supported coping factor, as venting of emotions could be 
considered a maladaptive approach 130, 153. 
8.1.4 Mediational model of avoidant coping and illness perception in 
anxiety and depression 
This thesis examined the theoretical underpinnings of the pathways between coping 
style, illness perception and emotional distress. The findings in Study III support the 
theory of dispositional coping, i.e. the coping style is rather stable over time and 
situations 121, 219. This means that an individual with CHF who displays a 
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dispositional avoidant coping approach has a tendency to respond with avoidant 
coping in stressful situations, and thereby influence a malignant illness perception 
and increased emotional distress.  
The findings in Study III showed a novel pattern between coping style, illness 
perception and emotional distress in patients with CHF which has not, to the 
author’s knowledge, been revealed before. Avoidant coping style influenced anxiety 
and depression both directly and partly mediated by the patient’s perception of 
control and illness burden. These results are, in part, supported by previous research 
showing negative associations between perceived symptom burden and personal 
control, with anxiety and depression as well as with behavioural disengagement 
considered as an avoidant coping strategy 153. However, the previous research only 
supports correlational associations and not a mediating pattern between these 
variables, since this has never been explored before. Possible explanations for the 
mediating pathways found in Study III could be that avoidant coping influences the 
patients with CHF to be less likely to self-manage CHF. Consequently, the patient 
might experience more symptoms of CHF when, for example, not self-monitoring 
CHF symptoms. Lack of self-management has been found in research to be related 
to emotional distress 220. Another explanation could be that avoidant coping asserts 
an adverse influence on self-efficacy, a control-related construct conceptually 
proximal to personal control, meaning the individual will have less confidence in 
engaging in self-management 221. Low self-efficacy has been associated with 
greater anxiety and depression in patients with CHF 64. The conceivable 
explanations can also be viewed in the light of the situation-specific theory of heart 
failure self-care where self-efficacy is highlighted as a personal factor that might 
influence the self-care process 56. However, these possible explanations for the 
mediating pathways with regard to self-management in patients with CHF need to 
be investigated in empirical research. 
8.1.5 Evaluation of a coping effectiveness training intervention  
In Study IV, a nurse-led coping effectiveness intervention for patients with CHF 
was evaluated. The theory based intervention, CET, consisted of training coping 
skills and appraisal of stress and was hypothesized to improve emotional well-
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being, HRQoL and clinical outcomes. Changes in coping styles and appraisal of the 
illness, such as the perceived control and illness burden, were also examined since 
these factors were assumed to mediate the effect of the intervention on the outcome 
measures.  
Although the PROMs of the primary endpoint (emotional well-being) and 
secondary endpoint (HRQoL) had a consistent pattern of improved average mean 
scores in line with the hypothesis of Study IV, they rendered non-significant. 
Previous research on a psychoeducational intervention for patients with CHF has 
shown reduced emotional distress during a 6-months period and improved HRQoL 
173. However, in the study by Sullivan et al. 173 the disease-specific Kansas City 
Cardiomyopathy Questionnaire (KCCQ) was used to measure HRQoL which has 
been proven to be a more sensitive instrument than, for example, SF-36 222 
equivalent to RAND 36 193 utilized in Study IV. 
When participants who self-assessed clinical scores on anxiety and/or depression as 
part of the primary endpoint were excluded from the analysis, a significant main 
intervention effect was found on reduced negative affect directly and six months 
after the CET for the participants who underwent the intervention. This result might 
indicate that the CET intervention is most suitable for patients with no or mild 
symptoms of anxiety and depression. Patients who suffer from more severe 
symptoms of anxiety and depression might need individual treatment; on the other 
hand, no negative effects for these patients were indicated. Previous research with a 
nurse-led depression care management provided in an individual-centered approach 
to reduce depression, showed positive results 174. The finding in Study IV highlights 
that a group intervention might be favorable for an identified group of patients 
when it comes to efforts for reducing emotional distress.  
The tertiary outcome, i.e. clinical outcomes as measured by readmission and death 
as well as total time for inpatient care cardiovascular cause and all cause, did not 
have a significant effect from the CET intervention. The result is consistent with 
former research 173. Even though CET has been evaluated in other patient groups 177, 
178, clinical outcome measures have never been included in the evaluations. Since 
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Study IV evaluates clinical outcomes of the CET intervention for the first time the 
results contribute to unique information. 
The CET intervention increased the perception of having personal control over the 
illness in the intervention group. This intervention effect was found after six weeks 
but was not sustained long term. Previous research has pointed out the perception of 
being in control as an important factor for individuals living with CHF, as it has 
been shown to be of importance in outcomes such as anxiety, depression, hostility, 
functional status and HRQoL 153, 223. In Study III the perception of being in more 
control over the illness influenced a reduction in depression. Even though 
perception of control increased significantly in the intervention group depression 
did not significantly decrease, albeit a lower average mean score was found. This 
could be explained by the underlying mechanism elucidated in Study III where, 
apart from illness perception, avoidant coping style played a major role for 
emotional distress and avoidant coping was not impacted by the CET intervention. 
In fact, there was no main intervention effect for any of the coping styles. As 
discussed previously, the measurement of coping styles in this thesis appears to 
assess a rather stable form of coping style independent of time and situation 121, 
therefore, it might be difficult to influence the coping styles. However, the emotion 
focused coping style demonstrated a significant interaction effect with time where, 
interestingly, the emotion focused coping increased in the control group whereas it 
decreased in the intervention group. According to the theory of stress and coping 115 
emotion focused coping is an adaptive approach when individuals have less control 
over the situation and cannot solve the problem. Since CHF is a chronic condition 
that involves self-care management in order to maintain health, e.g. flexible diuretic 
intake, weight monitoring and physical exercise 15, one could argue that emotion 
focused coping is a maladaptive approach. Because the intervention group had 
increased sense of control their need for emotion focused strategies to cope with 
their situation might have been less than it was for the control group. 
Longer term positive effects of CET have been found when applied to patients with 
HIV, where an additional maintenance phase followed the completion of the CET 
sessions 177. In order to achieve a sustainable longer term effect an additional 
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maintenance phase to the intervention design could, therefore, be suggested when 
applying it to patients with CHF. In addition, the CET could be further adjusted by 
incorporating training on specific strategies to prevent relapse in stress reactions as 
well as strategies to maintain new skills in coping and appraisal acquired during the 
CET. 
Despite the modest intervention effect the participants’ written evaluation, directly 
after completing the CET intervention, revealed satisfaction with the intervention 
and perceived benefits from the CET. For instance, meeting other people with CHF 
was seen as a positive experience. Indeed, meeting and having discussions with 
other people with CHF is an integral part of the CET intervention. However, it is 
not the only component of the CET taking into account the rigour and strengths of 
the intervention design being based on: a theory of stress and coping 115, having an 
adapted manual and workbook, well thought through themes for every session and 
home assignments. The CET intervention appears to provide psychosocial support 
and, in its essence, teaches skills for psychosocial self-care. In Orem’s theory of 
self-care the balance between self-care abilities and self-care deficits can be upheld 
in a nursing system, where a nursing system can support the patient in developing 
self-care abilities 55. In the light of the theory of self-care the CET intervention 
could be viewed as a supportive nursing system, where the aim is for the patient to 
reach a psychosocial self-care balance. 
8.2 METHODOLOGICAL CONSIDERATIONS 
In Studies I and III, the non-experimental cross sectional designs of the studies 
cannot empirically establish causality of the included variables in the analyses. 
However, the empirical data in the studies can provide consistency with the 
hypothesized and theoretical causality of the variables in the models 224. In Study 
III, advanced statistical methodology with SEM extend the results beyond the 
purely correlational to provide a data-supported sound theoretical model of coping, 
illness perception and emotional distress 209, 224.  
The measurement of the coping styles in this thesis was indicated to assess 
dispositional coping, a rather stable form of coping. Hence, the theoretical models 
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in Study III should also be examined using measurements of situational coping 115 
or domain specific coping, i.e. coping strategies varying in different life domains 
225. This could also explain why there was no significant intervention effect on the 
coping styles in Study IV.  
In this thesis, a generic measurement of HRQoL was chosen 193. The advantage 
with a generic instrument is that the results can be compared to those of healthy 
people or people living with other illnesses. RAND 36, utilized in this thesis, has 
been widely used to measure HRQoL 102. Most of the patients with CHF also have 
co-morbidities to be taken into account 226 hence a generic HRQoL measurement 
could be more appropriate. Stating this, disease specific measurement of HRQoL in 
patients with CHF has proven to be more sensitive 222.  
Since there is no clear definition of emotional well-being it is consequently 
indistinct how the concept should be operationalized. In this thesis emotional well-
being was measured by positive and negative affect, as well as by depression and 
anxiety. While affect is a recognized measurement of emotional well-being 71 one 
might argue that anxiety and depression measure emotional distress or possibly 
impaired emotional well-being. Nevertheless, emotional well-being and emotional 
distress are not entirely independent from one another but rather interact in a 
dynamic process 81, therefore, it is important to measure both aspects to retrieve a 
broad picture of a person’s emotional state. 
The self-assessment questionnaires utilized in this study have shown good 
psychometric properties in the CHF population as described in the methods-section. 
However, the internal consistency as measured by Cronbach’s alpha has been rather 
low for the higher order coping factors in the studies, except for avoidant coping 
and socially supported coping in Study I and problem focused coping in Study II. 
The higher order coping factors constitute broad theoretical constructs and therefore 
internal consistency might not be the optimal approach to measure reliability 227, 228. 
Test-retest reliability could have been another approach 229.  
Due to novelty of the CET intervention, it was difficult to estimate a clinically 
relevant a priori effect size. The observed effect sizes, as measured by Cohen’s d, 
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of the significant main intervention effects were in the range of small to medium, 
where Cohen’s criteria for effect size regard ≥ 0.2 as small and ≥ 0.5 as medium 230. 
It is possible that there could have been a potential lack of power for detecting a 
hypothesized intervention effect on the outcome measures in Study IV. Despite this, 
there were still some significant results found. The analyses were carried out firstly 
with ITT and secondly with PP. Analysis with ITT could enhance the risk of a type 
II error, whereas analysis with PP might introduce a biased treatment effect 231. The 
randomization process should, however, reduce the risk of bias in allocation of 
randomization group 232 and there were no significant differences between the two 
randomization groups in this thesis. 
The attrition rate was higher in the intervention group than in the control group at 
baseline. An explanation for this could partly be that the CET intervention required 
the participants to engage and commit during a two-month period, which may not 
have been possible for some owing to logistical reasons, illness or lack of energy. 
This could also explain why only 20 percent out of the eligible patients accepted to 
join the study, which could potentially be a selection bias. Consequently, the 
generalisability of the results is limited to patients with CHF who are physically 
mobile and in NYHA class II or III. The exclusion criteria also pose a limitation to 
generalisability, where the results cannot be generalised to patients with CHF who 
have a co-morbidity of another severe illness, psychiatric diagnosis or cognitive 
impairment, as well as to patients who can’t speak the Swedish language. This 
limitation of generalisability also extends to the results of Studies I-III in this thesis. 
When reporting a randomized controlled trial, transparency is crucial in order for 
the readers to understand its design, conduct, analysis and interpretation. Therefore, 
the Consolidated Standards of Reporting Trials (CONSORT) statement has been 
developed with a checklist and flow diagram for researchers to follow 232. It was the 
author’s intention to be as transparent as possible in this thesis when reporting the 
RCT in Study IV. This is particularly necessary since the author was involved in all 
stages of the study and had different roles, such as group leader, researcher and 
heart failure nurse. There were both strengths and limitations in having had multiple 
roles. The strengths were that being involved in all phases provided a 
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comprehensive overview, understanding and insight. The consistency of adherence 
to the study protocol was also most likely to have been enhanced when monitored 
by the same person. The participants might have had more confidence in the author 
as a group leader due to the author’s multiple roles and, consequently, they may 
have experienced a safe environment during the sessions. 
The limitations of having had several roles could be that the results from the 
evaluations of the intervention could have been influenced by the participants 
wanting to please the group leader/author of this thesis. Social desirability bias, 
when utilizing patient reported outcomes, and as a consequence threatening the 
validity of the results, has been discussed and evaluated in research but the results 
are inconclusive. Whereas some studies have pointed out the occurrence of social 
desirability bias 233, a recent study has reported absence of social desirability bias 
when evaluating a chronic disease self-management intervention 234. The strength of 
utilizing PROM is that it is a patient-centered method for evaluating an 
intervention. Furthermore, the endpoints or concepts measured with the self-
assessment questionnaires in this thesis are subjective and can only be assessed by 
the patients themselves 235. One could argue that an effect of the CET intervention 
is dependent on the group leader. This is somewhat controlled by standardization, as 
the group leader is following a manual when leading the sessions. The group leader 
should guide the discussions not dominate them. Therefore, the group leader kept in 
the background when the participants had a discussion amongst themselves.  
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9 CONCLUSIONS 
Utilization of different coping strategies does not appear to be influenced by 
functional status, age or gender, but rather by personal resources such as sense of 
coherence in patients with CHF.  
Avoidant coping style, i.e. denial, behavioural disengagement and substance use, is 
a maladaptive coping strategy for patients with CHF. Avoidant coping is associated 
with increased negative affect, depression and anxiety as well as worse HRQoL. 
Furthermore, avoidant coping appears to influence a malignant symptom perception 
and low sense of control over the illness. 
The influence of avoidant coping on emotional distress is not only a straightforward 
link but is also mediated by perceived symptom burden and personal control over 
the illness, in individuals with CHF. 
A four factorial structure of Brief COPE, a self-assessment questionnaire for 
measuring coping strategies, presented the best psychometric properties supported 
by theoretical assumptions and empirical data in patients with CHF. The structure 
consisted of avoidant coping, problem focused coping, emotion focused coping and 
socially supported coping. 
A nurse-led group based intervention through CET seems to provide psychosocial 
support for patients with CHF. CET increased the sense of control at 6 weeks after 
the intervention. CET also reduced negative affect in patients with no or mild 
symptoms of anxiety and depression at post-intervention and at 6 months after the 
intervention.  
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10 CLINICAL IMPLICATIONS 
Since avoidant coping has several adverse effects on health outcomes in patients 
with CHF, it is important to have approaches to identify avoidant coping. A four 
factorial assessment model of Brief COPE may facilitate the assessment of coping 
strategies in patients with CHF, compared to having 14 coping strategies to take 
into account.  
Enhancing the patients’ beliefs about personal control over the illness may 
contribute to improved emotional well-being in patients with CHF. Interventions 
that target both illness perception and coping are important in order to reduce 
emotional distress in patients with CHF. The CET intervention is a theory based 
intervention that provides evidence-based psychosocial support, and in extension, 
skills to engage in psychosocial self-care for patients with CHF in a systematic 
standard procedure.  
A nurse-led coping effectiveness intervention is feasible to implement in clinical 
practice for patients with CHF in order to enhance personal control over the illness.  
Patients with CHF who suffer from clinical depression and/or anxiety may need 
individual treatment, while the patients with mild or no symptoms of emotional 
distress might benefit from the group-based CET-intervention in reducing negative 
affectivity. 
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11 FUTURE RESEARCH 
Longitudinal studies on the associations between coping, illness perception and 
emotional distress should be carried out in order to establish causality between these 
variables. For further clarification of the pathways self-management of CHF might 
be an important variable to measure in this context of research. Clinical outcome 
measures could also be examined in such studies in order to investigate the linkages 
between psychological and somatic variables. Furthermore, if these studies were 
equipped with sufficient power to enable subgroup analysis, potential differences 
between subgroups could be explored further.  
Further research could be conducted regarding different designs of CET, such as an 
additional maintenance period to examine sustainable long-term effects, and online 
CET intervention. The purpose of the online CET intervention would be to make it 
accessible to a wider range of patients. Further controlled studies with CET 
intervention in patients with CHF, such as a multicenter study, should be carried out 
in order to verify and extend the results in this thesis. 
Since the CET intervention is being applied for the first time to patients with CHF, 
additional qualitative evaluation of the CET intervention with interviews could be 
carried out in order to gather an in-depth knowledge of the participants’ experience.  
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12 SVENSK SAMMANFATTNING 
Bakgrund: Hjärtsvikt är ett allvarligt och obotligt syndrom som drabbar ungefär 
två procent av befolkningen och prevalensen ökar med stigande ålder, där mer än 
10 procent av befolkningen över 70 år har hjärtsvikt. Prognosen och symptom-
bördan vid hjärtsvikt är jämförbar med många cancerdiagnoser. Personer som har 
hjärtsvikt har sämre hälsorelaterad livskvalitet jämfört med normalbefolkningen i 
samma ålder och förekomsten av depression och ångest är hög. Forskning har visat 
att sämre hälsorelaterad livskvalitet, depression och ångest predicerar en ökad 
dödlighet och återinläggning på sjukhus hos patienter med hjärtsvikt. Trots detta 
uppmärksammas sällan psykosociala aspekter och de får följaktligen ingen vård och 
behandling för detta. Coping (stresshantering), d.v.s. hur en person bedömer och 
bemästrar en stressfylld situation, som individen tillämpar för att t.ex. anpassa sig 
för att leva med hjärtsvikt, och sjukdomsuppfattning har visat sig i forskning ha 
betydelse för det emotionella välbefinnandet. 
Syfte: Det övergripande syftet med avhandlingen var att samla vetenskaplig 
evidens hur sjukdomsuppfattning, coping och känsla av sammanhang påverkar 
emotionellt välbefinnande hos patienter med hjärtsvikt. Samt att fastställa en 
teoretisk och empiriskt grundad mätmodell för att mäta copingstrategier. Vidare att 
utveckla, implementera och utvärdera en sjuksköterskeledd psykosocial 
intervention i syfte att förbättra patienternas adaptiva copingförmåga, sjukdoms-
uppfattning, emotionella välbefinnande och hälsorelaterade livskvalitet samt att 
minska återinläggning på sjukhus. 
Metoder: Studierna I-III hade en tvärsnittsdesign. Studie I undersökte vilka 
faktorer som kan inverka på coping och hur coping inverkar på emotionellt väl-
befinnande. Studie II var en metodologisk studie som undersökte en högre faktor-
struktur av Brief COPE, ett självskattningsformulär som mäter copingstrategier. 
Studie III analyserade två uppställda hypotetiska modeller av medierande effekt av 
coping och sjukdomsuppfattning på depression och ångest. Studie IV var en rand-
omiserad kontrollerad studie där en psykosocial intervention, Coping Effectiveness 
Training (CET), anpassat till patienter med hjärtsvikt utvärderades under ett år efter 
avslutad intervention. Det primära utfallsmåttet var emotionellt välbefinnande, det 
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sekundära utfallsmåttet var hälsorelaterad livskvalitet och det tertiära utfallsmåttet 
var återinläggning på sjukhus och död. Alla studier använde patientrapporterade 
data och kliniska data inhämtades via patienternas medicinska journaler. 
Resultat: Känsla av sammanhang var negativt associerat med dysfunktionella 
copingstrategier. Yngre ålder och manligt kön var signifikant associerat med högre 
användning av alkohol och/el droger som copingstrategi (p < 0.01) (I). En fyrfaktor-
modell av Brief COPE innehållande problemfokuserad, känslofokuserad, socialt 
stödjande och undvikande coping visade sig ha bäst psykometriska egenskaper (II). 
Högre grad av användande av undvikande coping, t.ex. förnekande eller ägna sig åt 
distraherande aktiviteter för att inte behöva ta itu med sin situation, var signifikant 
associerat med högre nivåer av negativ sinnesstämning (I), och ångest och 
depression (III) samt sämre hälsorelaterad livskvalitet (II). Undvikande coping 
visade sig även påverka en lägre känsla av kontroll samt högre uppfattad 
sjukdomsbörda, vilket i sin tur gav högre nivåer av ångest och depression (III). CET 
(IV) förbättrade känslan av kontroll över sin sjukdom hos de deltagare som 
randomiserats till interventionsgrupp (IG) jämfört med de deltagare som 
randomiserats till kontrollgrupp (KG) (p = 0.036). Förbättrade medelvärden på 
emotionellt välbefinnande och hälsorelaterad livskvalitet upptäcktes också hos IG 
jämfört med KG men skillnaderna var inte statistiskt signifikanta. När patienter som 
hade kliniska nivåer av ångest och/el depression exkluderades, visade det sig att 
negativ sinnesstämning minskade signifikant hos IG jämfört med KG (p = 0.022). 
Tid till kardiovaskulär återinläggning eller död var icke-signifikant lägre hos IG än 
hos KG, HR 0.58 (0.29-1.18), kontrollerat för kön och ålder. 
Slutsatser: Inre resurser snarare än ålder, kön och allvarlighetsgrad i hjärtsvikten, 
inverkar på coping hos patienter med hjärtsvikt. En fyrfaktormodell för att mäta 
copingstrategier visade sig vara en reliabel och valid modell för att underlätta 
mätningen. Undvikande coping har en ogynnsam inverkan på emotionellt väl-
befinnande och känslan av kontroll samt sjukdomsbörda. CET visade sig öka 
känslan av kontroll över sin sjukdom hos patienter med hjärtsvikt. Dessutom 
minskade CET negativ sinnesstämning hos de individer som inte hade måttlig till 
svår ångest och/el depression.  
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